Orion Research Solutions
Back to products
Orion Research Solutions

Tesamorelin 12mg / CJC-1295 3mg / Ipamorelin 6mg / GHRP-2 3mg Blend

Tesamorelin 12 mg / CJC-1295 3 mg / Ipamorelin 6 mg / GHRP-2 3 mg

Professional Product Render Coming Soon

Growth Hormone & Performance

Tesamorelin 12mg / CJC-1295 3mg / Ipamorelin 6mg / GHRP-2 3mg Blend

MOQ 10 units

This four-component blend combines Tesamorelin, CJC-1295, Ipamorelin, and GHRP-2, assembling two GHRH-pathway analogs with two ghrelin receptor secretagogues for comprehensive somatotroph axis research. Combining two GHRH-pathway analogs with two secretagogues of differing selectivity, it supports investigation of receptor saturation and ceiling effects across the somatotropic axis.

Volume pricing

Priced on request. Contact us for a wholesale quote.

Request a Quote

Volume pricing is based on the quantity ordered per product. Minimum order quantity: 10 units per product.

Research Overview

This formulation represents the most complex combination in the growth hormone category, pairing two distinct GHRH receptor agonists — Tesamorelin, a DPP-4-resistant GHRH(1-44) analog associated with visceral adipose effects, and CJC-1295, a modified GHRH(1-29) analog — with two GHS-R1a secretagogues of differing selectivity profiles, Ipamorelin and GHRP-2. The research rationale is comprehensive axis engagement: recruiting both GHRH receptor variants and both ends of the secretagogue selectivity spectrum within a single controlled formulation. Investigators use such combinations to examine ceiling effects, receptor saturation, and whether multi-component stimulation produces output beyond simpler pairings. Laboratory applications include maximal somatotroph stimulation protocols, receptor saturation studies, comparative multi-agent pharmacology, and endocrine profiling across combination arms.

Common Research Areas

  • Growth hormone axis research
  • GHRH receptor pharmacology
  • Ghrelin receptor signaling
  • Receptor saturation studies
  • Combination pathway research
  • Endocrine profiling

Key Features

  • Presentation: Lyophilized vial (blend) at Tesamorelin 12 mg / CJC-1295 3 mg / Ipamorelin 6 mg / GHRP-2 3 mg
  • Category: Growth Hormone & Performance — wholesale supply only
  • Minimum order quantity: 10 units per SKU
  • Applied in growth hormone axis research and ghrh receptor pharmacology
  • Cold-chain handling: store at 2–8°C, protected from light
  • Research Use Only — not for human or animal consumption

Product Information

Category
Growth Hormone & Performance
Format
Lyophilized vial (blend)
Strength
Tesamorelin 12 mg / CJC-1295 3 mg / Ipamorelin 6 mg / GHRP-2 3 mg
Minimum Order Quantity
10 units
Wholesale Availability
Wholesale only

Why Researchers Choose This Product

Manually combining four peptides at a fixed ratio is impractical to reproduce across an entire study. This co-formulation makes multi-component axis research feasible by holding all four ratios constant, which is a prerequisite for interpretable ceiling-effect data.

Storage

Store lyophilized vials refrigerated at 2–8°C. Protect from heat and light. Reconstituted material should be kept refrigerated and handled under aseptic laboratory conditions. For laboratory research use only.

Frequently Asked Questions

What is Tesamorelin 12mg / CJC-1295 3mg / Ipamorelin 6mg / GHRP-2 3mg Blend studied for?
This four-component blend combines Tesamorelin, CJC-1295, Ipamorelin, and GHRP-2, assembling two GHRH-pathway analogs with two ghrelin receptor secretagogues for comprehensive somatotroph axis research. Combining two GHRH-pathway analogs with two secretagogues of differing selectivity, it supports investigation of receptor saturation and ceiling effects across the somatotropic axis.
What research applications does Tesamorelin 12mg / CJC-1295 3mg / Ipamorelin 6mg / GHRP-2 3mg Blend support?
Reported laboratory applications span growth hormone axis research, ghrh receptor pharmacology, ghrelin receptor signaling, receptor saturation studies, combination pathway research, and endocrine profiling. Manually combining four peptides at a fixed ratio is impractical to reproduce across an entire study. This co-formulation makes multi-component axis research feasible by holding all four ratios constant, which is a prerequisite for interpretable ceiling-effect data.
What format, strength, and minimum order apply?
Tesamorelin 12mg / CJC-1295 3mg / Ipamorelin 6mg / GHRP-2 3mg Blend is supplied as lyophilized vial (blend) at Tesamorelin 12 mg / CJC-1295 3 mg / Ipamorelin 6 mg / GHRP-2 3 mg. The minimum order quantity is 10 units per SKU, and it is available to wholesale buyers only — laboratories, research organizations, distributors, and qualified commercial accounts.
How should this product be stored and handled?
Store lyophilized vials refrigerated at 2–8°C. Protect from heat and light. Reconstituted material should be kept refrigerated and handled under aseptic laboratory conditions. For laboratory research use only.
Is this product suitable for human or animal use?
No. This product is supplied strictly for laboratory and scientific research by qualified professionals. It is not for human or animal consumption, is not intended for human or veterinary use, and is not approved to diagnose, treat, cure, or prevent any disease.

Important Notice

Research Use Only. Not for human or animal consumption. These products are intended exclusively for laboratory and scientific research by qualified professionals. They are not intended for human or veterinary use and are not approved to diagnose, treat, cure, or prevent any disease.

This product is intended exclusively for laboratory research and analytical purposes. NOT FOR HUMAN CONSUMPTION. Not intended to diagnose, treat, cure, or prevent any disease.